Sign in / Join Now
ETFs & Funds
...any thoughts? 2013 Ops loss lowest since IPO; Q4 interest expense ($0.9m) vs. ($2m); Q4 net loss ($0.23/sh) vs. (($0.55/sh)
2013 net loss would be ($1.29/sh) w/o $54m related to amortization of conv.debt discount; cash/cash equiv. $13m vs. $7.8
paid down all short-term debt; 510(k) to be submitted this quarter.
distribution agreement with "Medix Japan, Inc. and Hokushin Medical Co. Ltd. to distribute its Niobe® Magnetic Navigation System"
Add a reply...
Latest StockTalks »
people get STXS breaking news and analysis by email alert.
Get email alerts on STXS »
Get latest price
From other sites
Stereotaxis To Report Third Quarter 2016 Financial Results On November 7, 2016
at TheStreet (Nov 2, 2016)
Robert Wood Johnson University Hospital Physician Surpasses 500 Procedures Using Stereotaxis Niobe® System
at TheStreet (Oct 25, 2016)
Stereotaxis Technologies To Be Highlighted At Society For Cardiac Robotic Navigation's Inaugural Meeting In Amsterdam
at TheStreet (Oct 18, 2016)
Stereotaxis Awarded Patent In China For Vdrive® System With V-Loop™ Manipulator
at TheStreet (Oct 13, 2016)
UCLA Medical Center Implements Latest Stereotaxis Technology With Upgrade To Niobe® ES Remote Magnetic Navigation System
at TheStreet (Oct 5, 2016)